AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 237.59 billion as of December 5, 2025. Its market cap has increased by 27.53% in one year.

Market Cap

237.59B

Enterprise Value

226.81B

Revenue

3.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,510.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 237.59B, a decrease of -43.87%. That is a compound annual growth rate of -8.52%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	237.59B	38.75%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.96T
Celltrion	40.11T
ALTEOGEN	24.41T
ABL Bio	10.51T
SK Biopharmaceuticals	10.49T
Yuhan	8,755.13B
LigaChem Biosciences	6,753.15B
Peptron	6,645.44B

Market Cap Rankings